lidoflazine has been researched along with Glioblastoma in 1 studies
Lidoflazine: Coronary vasodilator with some antiarrhythmic action.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, J | 1 |
| Kang, H | 1 |
| Son, B | 1 |
| Kim, MJ | 1 |
| Kang, J | 1 |
| Park, KH | 1 |
| Jeon, J | 1 |
| Jo, S | 1 |
| Kim, HY | 1 |
| Youn, H | 1 |
| Youn, B | 1 |
1 other study available for lidoflazine and Glioblastoma
| Article | Year |
|---|---|
NRBF2-mediated autophagy contributes to metabolite replenishment and radioresistance in glioblastoma.
Topics: Animals; Autophagy; Autophagy-Related Proteins; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Di | 2022 |